Inventor
JAYAPRAKASH K. NAIR
Inventor
US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
C12NMicroorganisms or enzymes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07HSugars11%
C07CAcyclic or carbocyclic compounds10%
C07DHeterocyclic compounds8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
Y02PClimate change mitigation technologies in the production or processing of goods5%
C12YEnzymes3%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
12,397,013Extrahepatic delivery202512,364,762Biodegradable lipids for the delivery of active agents202512,350,338Biodegradable lipids for the delivery of active agents202512,343,398Biodegradable lipids for the delivery of active agents202512,275,938Modified RNA agents with reduced off-target effect202512,247,203Modified RNA agents with reduced off-target effect202512,239,709Biodegradable lipids for the delivery of active agents202512,221,607Multi-targeted single entity conjugates202512,173,288Oligonucleotide-ligand conjugates and process for their preparation202412,059,468Carbohydrate conjugates as delivery agents for oligonucleotides202412,005,074Extrahepatic delivery202411,944,687Carbohydrate conjugate RNA agents and process for their preparation202411,725,207Serpina1 iRNA compositions and methods of use thereof202311,666,653Carbohydrate conjugates as delivery agents for oligonucleotides202311,597,932Chirally-enriched double-stranded RNA agents202311,504,391Modified RNA agents with reduced off-target effect202211,420,931Lipid containing formulations202211,286,482Endosomal cleavable linkers2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ALNYLAM PHARMACEUTICALS INC (17)· patent assignee history
2022Patents assigned to ARBUTUS BIOPHARMA CORP (1)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 17 | 2022–2025 |
| ARBUTUS BIOPHARMA CORP | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 18 | 2022–2025 |